Biomarkers in Routine Heart Failure Clinical Care
Heart failure is a clinical condition with complex pathophysiology that involves many different processes. Diagnosis is often difficult in patients presenting for the first time with breathlessness. Many biomarkers have been identified that are elevated in heart failure and their role in assessing p...
Guardado en:
Autores principales: | Sunil K Nadar, Muhammad Mujtaba Shaikh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/26939f98cb2b47ff85b9fdda0edab849 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time
por: Sunil K Nadar, et al.
Publicado: (2019) -
Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure
por: Izabella Uchmanowicz, et al.
Publicado: (2019) -
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
por: M Rizzo, et al.
Publicado: (2020) -
Representation of Women Physicians in Heart Failure Clinical Practice
por: Ersilia M DeFilippis, et al.
Publicado: (2021) -
The New Heart Failure Association Definition of Advanced Heart Failure
por: Marco Metra, et al.
Publicado: (2019)